Maarten Slagter

5.4k total citations · 4 hit papers
9 papers, 2.0k citations indexed

About

Maarten Slagter is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Maarten Slagter has authored 9 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Maarten Slagter's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (4 papers). Maarten Slagter is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (4 papers). Maarten Slagter collaborates with scholars based in Netherlands, United States and Austria. Maarten Slagter's co-authors include Ton N. Schumacher, Lodewyk F.A. Wessels, Riccardo Mezzadra, Leonie Voorwerk, Marleen Kok, JT Chang, Mustafa Khasraw, Daniel J. McGrail, Naoto T. Ueno and JK Litton and has published in prestigious journals such as Nature, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Maarten Slagter

9 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

2021 672 citations Daniel J. McGrail, Leonie Voorwerk et al. Annals of Oncology profile →
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators

2017 504 citations Riccardo Mezzadra, Chong Sun et al. Nature profile →
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

2018 373 citations Wouter Scheper, Sander Kelderman et al. Nature Medicine profile →
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

2019 361 citations Max D. Wellenstein, Seth B. Coffelt et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maarten Slagter Netherlands	7	1.4k	937	598	411	373	9	2.0k
Jason Madore Australia	25	1.6k 1.2×	1.0k 1.1×	756 1.3×	459 1.1×	320 0.9×	32	2.5k
Li-Chuan Chan Taiwan	17	1.2k 0.8×	779 0.8×	965 1.6×	425 1.0×	406 1.1×	27	2.1k
Dario Sangiolo Italy	25	1.4k 1.0×	1.1k 1.2×	549 0.9×	442 1.1×	200 0.5×	76	2.2k
Orianne Colussi France	6	1.2k 0.9×	741 0.8×	475 0.8×	415 1.0×	293 0.8×	10	1.8k
Eva Muñoz‐Couselo Spain	20	1.6k 1.2×	574 0.6×	598 1.0×	418 1.0×	446 1.2×	89	2.1k
Chie Kudo‐Saito Japan	22	1.2k 0.9×	968 1.0×	793 1.3×	303 0.7×	327 0.9×	41	2.0k
Serena S. Kwek United States	20	1.5k 1.1×	1.2k 1.3×	701 1.2×	323 0.8×	236 0.6×	27	2.3k
Lucas Ferrari de Andrade United States	16	1.6k 1.1×	1.6k 1.7×	666 1.1×	328 0.8×	217 0.6×	29	2.6k
Sasha E. Stanton United States	15	1.1k 0.8×	596 0.6×	530 0.9×	274 0.7×	398 1.1×	36	1.7k
Limo Chen United States	18	1.0k 0.7×	712 0.8×	816 1.4×	276 0.7×	257 0.7×	26	1.9k

Countries citing papers authored by Maarten Slagter

Since Specialization

Citations

This map shows the geographic impact of Maarten Slagter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Slagter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Slagter more than expected).

Fields of papers citing papers by Maarten Slagter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten Slagter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Slagter. The network helps show where Maarten Slagter may publish in the future.

Co-authorship network of co-authors of Maarten Slagter

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten Slagter. A scholar is included among the top collaborators of Maarten Slagter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten Slagter. Maarten Slagter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Hoekstra, Mirjam E., Maarten Slagter, Jos Urbanus, et al.. (2024). Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironment. Cancer Cell. 42(1). 157–167.e9. 41 indexed citations

2.

McGrail, Daniel J., Leonie Voorwerk, Maarten Slagter, et al.. (2021). High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types. Annals of Oncology. 32(5). 661–672. 672 indexed citations breakdown →

3.

Slagter, Maarten, Elisa A. Rozeman, Judith M. Versluis, et al.. (2020). Spatial proximity of CD8 T cells to tumor cells as an independent biomarker for response to anti-PD-1 therapy.. Journal of Clinical Oncology. 38(15_suppl). 10038–10038. 3 indexed citations

4.

Slagter, Maarten, et al.. (2019). Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression In Vivo. Cancer Research. 79(13). 3406–3416. 19 indexed citations

5.

Wellenstein, Max D., Seth B. Coffelt, Danique E. M. Duits, et al.. (2019). Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis. Nature. 572(7770). 538–542. 361 indexed citations breakdown →

6.

Kvistborg, Pia, Marit M. van Buuren, Daisy Philips, et al.. (2019). Abstract B022: Properties of T-cell-recognized neoantigens. Cancer Immunology Research. 7(2_Supplement). B022–B022. 1 indexed citations

7.

Scheper, Wouter, Sander Kelderman, Lorenzo F. Fanchi, et al.. (2018). Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nature Medicine. 25(1). 89–94. 373 indexed citations breakdown →

8.

Kok, Marleen, Leonie Voorwerk, Hugo M. Horlings, et al.. (2018). Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): Final response data stage I and first translational data.. Journal of Clinical Oncology. 36(15_suppl). 1012–1012. 34 indexed citations

9.

Mezzadra, Riccardo, Chong Sun, Lucas T. Jae, et al.. (2017). Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature. 549(7670). 106–110. 504 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact